Monoclonal antibody treatment and manufacturing on the scale of a global pandemic has never been tried before, Lilly CEO David Ricks said. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
